 RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--TransEnterix, Inc. NYSE American:TRXC, a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical UnitTM ISUTM that enables machine vision capabilities on the SenhanceR Surgical System. This approval will provide Senhance digital laparoscopic programs in Europe access to this new technology 